ReviewClinical and experimental nephrology2025
Nephron number variability in Japanese subjects: an autopsy-based study and its implications for chronic kidney disease: clinical scientist award address 2024.
Review in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of nephrons is a key determinant of blood pressure regulation and chronic kidney disease (CKD) progression. Although traditional estimates suggest approximately one million nephrons per kidney, modern stereological approaches reveal substantial variability, that is influenced by ethnicity, birth weight, and other early life factors. This review evaluates the century-long evolution of nephron number research, variations across racial and ethnic groups, and explores how factors, such as body size, aging, and lifestyle risks, influence nephron endowment. Techniques for nephron quantification, from design-based stereology to emerging in vivo imaging, are also discussed. Recent research suggests markedly lower nephron counts in Japanese populations, especially among individuals with hypertension or CKD. The autopsy-based investigation in the present study included 27 middle-aged to older Japanese men (9 normotensive, 9 hypertensive, and 9 participants with CKD) who underwent dissector-fractionator stereology to quantify non-sclerosed glomeruli. Normotensive men had an average of approximately 640,399 non-sclerosed glomeruli. In contrast, the hypertensive participants had approximately 392,108 non-sclerosed glomeruli and those with CKD had only 268, 043. These findings underscore the potential influence of limited nephron reserves on hypertension and CKD in Japan. Current evidence suggests that nephron number estimates can guide therapeutic decisions and predict CKD outcomes, while advancements in real-time imaging offer potential avenues for non-invasive nephron assessment. Collectively, these developments highlight the central importance of nephron quantity in nephrology and enable targeted interventions aimed at preserving kidney function and mitigating the CKD burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.